ProPhase Labs Inc (PRPH)
4.575
-0.04
(-0.76%)
USD |
NASDAQ |
Apr 30, 16:00
4.53
-0.04
(-0.98%)
Pre-Market: 20:00
ProPhase Labs Revenue (TTM): 44.38M for Dec. 31, 2023
Revenue (TTM) Chart
Historical Revenue (TTM) Data
| Date | Value |
|---|---|
| December 31, 2023 | 44.38M |
| September 30, 2023 | 62.71M |
| June 30, 2023 | 78.54M |
| March 31, 2023 | 94.42M |
| December 31, 2022 | 122.65M |
| September 30, 2022 | 145.98M |
| June 30, 2022 | 131.25M |
| March 31, 2022 | 111.30M |
| December 31, 2021 | 79.04M |
| September 30, 2021 | 39.05M |
| June 30, 2021 | 33.42M |
| March 31, 2021 | 27.90M |
| December 31, 2020 | 14.51M |
| September 30, 2020 | 12.49M |
| June 30, 2020 | 11.42M |
| March 31, 2020 | 9.446M |
| December 31, 2019 | 9.876M |
| September 30, 2019 | 10.83M |
| June 30, 2019 | 10.50M |
| March 31, 2019 | 12.04M |
| December 31, 2018 | 13.12M |
| September 30, 2018 | 13.18M |
| June 30, 2018 | 13.78M |
| March 31, 2018 | 12.50M |
| December 31, 2017 | 9.867M |
| Date | Value |
|---|---|
| September 30, 2017 | 6.483M |
| June 30, 2017 | 4.845M |
| March 31, 2017 | 3.961M |
| December 31, 2016 | 4.206M |
| September 30, 2016 | -6.484M |
| June 30, 2016 | -3.496M |
| March 31, 2016 | -2.326M |
| December 31, 2015 | 2.518M |
| September 30, 2015 | 21.41M |
| June 30, 2015 | 22.15M |
| March 31, 2015 | 21.76M |
| December 31, 2014 | 22.07M |
| September 30, 2014 | 22.70M |
| June 30, 2014 | 23.52M |
| March 31, 2014 | 23.66M |
| December 31, 2013 | 25.03M |
| September 30, 2013 | 24.51M |
| June 30, 2013 | 23.97M |
| March 31, 2013 | 23.93M |
| December 31, 2012 | 22.40M |
| September 30, 2012 | 20.79M |
| June 30, 2012 | 20.46M |
| March 31, 2012 | 20.31M |
| December 31, 2011 | 17.45M |
| September 30, 2011 | 16.18M |
Revenues Definition
Revenues measure the total amount of value that a company brings in during a certain period. This is also considered the "top-line" of the income statement. Revenues are used for all operating expenses as well as other line items which eventually lead to the net income for the company. Revenue is an extremely important metric when analyzing a company. A company with efficient margins is able to turn revenues into the most net income.
Revenue (TTM) Range, Past 5 Years
9.446M
Minimum
Mar 2020
145.98M
Maximum
Sep 2022
55.25M
Average
39.05M
Median
Sep 2021
Revenue (TTM) Benchmarks
| Fonar Corp | 102.42M |
| XWELL Inc | 30.11M |
| Applied DNA Sciences Inc | 8.996M |
| Veracyte Inc | 361.05M |
| OncoCyte Corp | 1.503M |